Grants per year
Personal profile
Certifications and Licenses
| Hematology | |
| Medical Oncology |
Training Experience
| 2001 | Residency, Dalhousie University, Canada |
| 2004 | Fellowship, Univ. of Illinois Hospital |
Education/Academic qualification
MD, McGill University
… → 1998
Research interests
- Head and Neck Cancer
- Salivary Gland Tumors
- Sarcomas
- Thyroid Cancer
Fingerprint Dive into the research topics where Mark Agulnik is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Sarcoma
Medicine & Life Sciences
Head and Neck Neoplasms
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Epidermal Growth Factor Receptor
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Protein-Tyrosine Kinases
Medicine & Life Sciences
Gastrointestinal Stromal Tumors
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2005 2024
Prot #GTI-4419-301: ROMAN: Reduction in Oral Mucositis with Avasopasem Manganese (GC4419) – Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Headand Neck Cancer
Clinical Assistance Programs, LLC, Galera Therapeutics, Inc.
9/19/19 → 9/19/22
Project: Research project
Research Output 2001 2019
A phase II clinical study of 13-deoxy, 5-iminodoxorubicin (GPX-150) with metastatic and unresectable soft tissue sarcoma
Van Tine, B. A., Agulnik, M., Olson, R. D., Walsh, G. M., Klausner, A., Frank, N. E., Talley, T. T. & Milhem, M. M., Jun 1 2019, In : Cancer medicine. 8, 6, p. 2994-3003 10 p.Research output: Contribution to journal › Article
Open Access
Sarcoma
Doxorubicin
Type II DNA Topoisomerase
Survival Rate
Leukopenia
Ectopic hamartomatous thymoma in an immunocompromised male
Waters, D., Obeidin, F., Alexiev, B. A., Musunuri, S. R., Peabody, T. D., Agulnik, M. & Yeldandi, A. V., Sep 1 2019, In : Pathology Research and Practice. 215, 9, 152497.Research output: Contribution to journal › Article
Thymoma
Keratins
Salivary Glands
Breast
Synovial Sarcoma
2
Citations
(Scopus)
Piloting a financial counseling intervention for patients with cancer receiving chemotherapy
Kircher, S. M., Yarber, J., Rutsohn, J., Guevara, Y., Lyleroehr, M., Jackson, H. A., Walradt, J., Desai, B., Mulcahy, M. F., Kalyan, A., Benson III, A. B., Agulnik, M., Mohindra, N. A., DeSouza, J. & Garcia, S. F., Mar 1 2019, In : Journal of oncology practice. 15, 3, p. E202-E210Research output: Contribution to journal › Article
Counseling
Drug Therapy
Neoplasms
Costs and Cost Analysis
Workflow
7
Citations
(Scopus)
Randomized double-blind phase II study of regorafenib in patients with metastatic osteosarcoma
Davis, L. E., Bolejack, V., Ryan, C. W., Ganjoo, K. N., Loggers, E. T., Chawla, S., Agulnik, M., Livingston, M. B., Reed, D., Keedy, V., Rushing, D., Okuno, S., Reinke, D. K., Riedel, R. F., Attia, S., Mascarenhas, L. & Maki, R. G., Jan 1 2019, In : Journal of Clinical Oncology. 37, 16, p. 1424-1431 8 p.Research output: Contribution to journal › Article
Osteosarcoma
Disease-Free Survival
Placebos
Sarcoma
Clinical Trials Data Monitoring Committees
49
Citations
(Scopus)
Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: An international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742)
Ma, B. B. Y., Lim, W. T., Goh, B. C., Hui, E. P., Lo, K. W., Pettinger, A., Foster, N. R., Riess, J. W., Agulnik, M., Chang, A. Y. C., Chopra, A., Kish, J. A., Chung, C. H., Adkins, D. R., Cullen, K. J., Gitlitz, B. J., Lim, D. W., To, K. F., Chan, K. C. A., Lo, Y. M. D. & 5 others, , Jan 1 2018, In : Journal of Clinical Oncology. 36, 14, p. 1412-1418 7 p.Research output: Contribution to journal › Article
Multicenter Studies
Survival Rate
Ligands
Disease-Free Survival
Biomarkers